Clinical utility and patient considerations in the use of ofatumumab in chronic lymphocytic leukemia

Treatment aim for chronic lymphocytic leukemia has been radically changed over the past years from providing only a palliative approach to reaching disease eradication and improving survival. Ofatumumab is a monoclonal humanized antibody with peculiar in vitro and in vivo properties, at present appr...

Descripción completa

Detalles Bibliográficos
Autores principales: Frustaci, Anna Maria, Tedeschi, Alessandra, Picardi, Paola, Cairoli, Roberto, Montillo, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583123/
https://www.ncbi.nlm.nih.gov/pubmed/26425075
http://dx.doi.org/10.2147/BTT.S60503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583123/
https://www.ncbi.nlm.nih.gov/pubmed/26425075
http://dx.doi.org/10.2147/BTT.S60503

Ejemplares similares